Drug repositioning and repurposing for Alzheimer disease
Clive Ballard(University of Exeter), Janet Sultana(University of Messina), Pat Doherty(King's College London), Gareth Williams(King's College London), José Luís Molinuevo(Pasqual Maragall Foundation), Dag Aarsland(King's College London), Jeffrey L. Cummings(University of California, Los Angeles), Tormod Fladby(University of Oslo), Roger Mills(King's College London), Anne Corbett(University of Exeter), John T. O’Brien(North Tyneside General Hospital)
Cited by 197
Related Papers
NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease
|Alzheimer s & Dementia|2018|10.4k
Multidisciplinary research priorities for the COVID-19 pandemic: a call for action for mental health science
|The Lancet Psychiatry|2020|6k
Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration
|The Lancet Neurology|2013|5.4k
Diagnosis and management of dementia with Lewy bodies
|Neurology|2017|4.4k
A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer's disease
|Alzheimer s & Dementia|2014|3.1k